Rivastigmine teva – charakterystyka4 [featured_image] RIVASTIGMINE TEVA, 13,3 mg/24 h, system transdermalny, plaster (Rivastigminum) Download is available until [expire_date] Version Download 3 File Size File Count 1 Create Date 28 listopada 2016 Last Updated 28 listopada 2016 Rivastigmine teva – charakterystyka4